Presentation is loading. Please wait.

Presentation is loading. Please wait.

José L. Morales et al. JACEP 2017;j.jacep

Published byRosa Kruse Modified over 6 years ago

Similar presentations

Presentation on theme: "José L. Morales et al. JACEP 2017;j.jacep"— Presentation transcript:

1 José L. Morales et al. JACEP 2017;j.jacep.2017.02.015
Number and Type of ILM Events According to CIED and Leads Involved CIED = cardiac implanted electronic device; CRT-D = cardiac resynchronization therapy device; ICD = implantable cardioverter defibrillator; ILM-r = idiopathic lead migration (reel); ILM-t = idiopathic lead migration (twiddler); LV = left ventricle; PM = pacemaker; RA = right atrium; RV = right ventricle. José L. Morales et al. JACEP 2017;j.jacep 2017 American College of Cardiology Foundation

Download ppt "José L. Morales et al. JACEP 2017;j.jacep"

Similar presentations

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol
by Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B

by Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B
David Filgueiras-Rama, and José Jalife JACEP 2016;2:1-13

David Filgueiras-Rama, and José Jalife JACEP 2016;2:1-13
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,
Tom F. Brouwer et al. JACEP 2016;2:89-96

Tom F. Brouwer et al. JACEP 2016;2:89-96
José L. Morales et al. JACEP 2017;j.jacep

José L. Morales et al. JACEP 2017;j.jacep
Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:
Prakash Harikrishnan et al. JACEP 2015;1:

Prakash Harikrishnan et al. JACEP 2015;1:
Clyde W. Yancy et al. JACC 2017;70:

Clyde W. Yancy et al. JACC 2017;70:
Tom F. Brouwer et al. JACEP 2016;2:

Tom F. Brouwer et al. JACEP 2016;2:
Wouter M. van Everdingen et al. JACEP 2015;1:

Wouter M. van Everdingen et al. JACEP 2015;1:
Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.
Konstantinos C. Siontis et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:
Tom F. Brouwer et al. JACEP 2016;2:89-96

Tom F. Brouwer et al. JACEP 2016;2:89-96
David D. Berg et al. JACC 2018;71:

David D. Berg et al. JACC 2018;71:
José L. Morales et al. JACEP 2017;j.jacep

José L. Morales et al. JACEP 2017;j.jacep
Thomas C. Crawford et al. JACEP 2017;3:

Thomas C. Crawford et al. JACEP 2017;3:
Thomas C. Crawford et al. JACEP 2017;j.jacep

Thomas C. Crawford et al. JACEP 2017;j.jacep

Similar presentations

Ads by Google